Neoadjuvant camrelizumab followed by concurrent camrelizumab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: a single-arm, phase II study.

Yinliang ShengXiangrui MengChunyang ZhangZhengzheng ShanFeng LiBin WuMengli XuAijia LiLulu GuanLidong ChenShuzhen SunYihui MaTaiying LuSong ZhaoQingxia FanYu QiFeng Wang

Published in: Journal of thoracic disease (2024)

In conclusion, neoadjuvant camrelizumab followed by camrelizumab plus chemotherapy showed promising efficacy in treating locally advanced ESCC and had a manageable safety profile.

Keyphrases

locally advanced
phase ii study
rectal cancer
neoadjuvant chemotherapy
squamous cell carcinoma
radiation therapy
lymph node
study protocol